Selected article for: "ARDS outcome and pulmonary inflammation"
Author: Hajjar, L. A.; Mauad, T.; Galas, F. R. B. G.; Kumar, A.; da Silva, L. F. F.; Dolhnikoff, M.; Trielli, T.; Almeida, J. P.; Borsato, M. R. L.; Abdalla, E.; Pierrot, L.; Kalil Filho, R.; Auler, J. O. C.; Saldiva, P. H. N.; Hoff, P. M.
Title: Severe novel influenza A (H1N1) infection in cancer patients
  • Document date: 2010_5_28
    • ID: 00rk8fb5_31
    Snippet: Corticosteroids were administered to all patients as Meduri et al. [27] recommend in ARDS cases with low PO 2 /FiO 2 . Steroid use has been reported in some cases of H1N1associated ARDS without any adverse outcome [28] . However, some authors discuss the potential adverse effects of steroids in H1N1 infection, including higher mortality possibly related to virus spreading [29] . Although there is no consensus about its efficacy in this disorder, .....
    Document: Corticosteroids were administered to all patients as Meduri et al. [27] recommend in ARDS cases with low PO 2 /FiO 2 . Steroid use has been reported in some cases of H1N1associated ARDS without any adverse outcome [28] . However, some authors discuss the potential adverse effects of steroids in H1N1 infection, including higher mortality possibly related to virus spreading [29] . Although there is no consensus about its efficacy in this disorder, and despite the belief that corticosteroid could reduce pulmonary inflammation and fibrosis in severe cases, our poor results suggest that this strategy will need to be carefully reevaluated in the future.

    Search related documents:
    Co phrase search for related documents
    • adverse effect and pulmonary inflammation: 1, 2
    • adverse effect and severe case: 1, 2, 3, 4, 5, 6
    • adverse outcome and ARDS case: 1
    • adverse outcome and H1N1 infection: 1, 2, 3, 4
    • adverse outcome and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • adverse outcome and severe case: 1, 2, 3, 4
    • ARDS case and H1N1 infection: 1
    • ARDS case and high mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • ARDS case and pulmonary inflammation: 1, 2
    • ARDS case and severe case: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29